期刊簡介預計審稿時間： 約1.0個月

Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means. Neuropharmacology publishes articles of any length (original research and reviews).

《神經(jīng)藥理學》發(fā)表神經(jīng)科學領(lǐng)域的高質(zhì)量原創(chuàng)研究和評論文章，尤其是包含神經(jīng)藥理學內(nèi)容的文章。但是，任何神經(jīng)科學領(lǐng)域的論文都會被考慮。該期刊通常不接受臨床研究，但可能會考慮人類臨床前神經(jīng)藥理學研究。該期刊只考慮那些實驗藥物的化學結(jié)構(gòu)和成分在文獻中很容易獲得或作者在提交的稿件中披露的投稿。只有在特殊情況下，才會考慮天然產(chǎn)品，而且只有在制備方法通過科學手段明確定義的情況下才會考慮。《神經(jīng)藥理學》發(fā)表任何長度的文章（原創(chuàng)研究和評論）。

《Neuropharmacology》(神經(jīng)藥理學)編輯部通訊方式為PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OX5 1GB。如果您需要協(xié)助投稿或潤稿服務，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務十年，熟悉發(fā)表政策，可為您提供一對一投稿指導，避免您在投稿時頻繁碰壁，節(jié)省您的寶貴時間，有效提升發(fā)表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內(nèi)容。